BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23109824)

  • 1. Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology.
    Zarogouldis P; Karamanos NK; Porpodis K; Domvri K; Huang H; Hohenforst-Schimdt W; Goldberg EP; Zarogoulidis K
    Int J Mol Sci; 2012; 13(9):10828-10862. PubMed ID: 23109824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.
    Zarogoulidis P; Darwiche K; Hohenforst-Schmidt W; Huang H; Li Q; Freitag L; Zarogoulidis K
    Future Oncol; 2013 Aug; 9(8):1171-94. PubMed ID: 23902248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in aerosol gene delivery systems using non-viral vectors for lung cancer therapy.
    Lee AY; Cho MH; Kim S
    Expert Opin Drug Deliv; 2019 Jul; 16(7):757-772. PubMed ID: 31282221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy.
    Hong SH; Park SJ; Lee S; Cho CS; Cho MH
    Expert Opin Drug Deliv; 2015 Jun; 12(6):977-91. PubMed ID: 25423167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol gene therapy for metastatic lung cancer using PEI-p53 complexes.
    Gautam A; Waldrep JC; Kleinerman ES; Xu B; Fung YK; T'Ang A; Densmore CL
    Methods Mol Med; 2003; 75():607-18. PubMed ID: 12407767
    [No Abstract]   [Full Text] [Related]  

  • 6. Aerosol gene therapy.
    Gautam A; Waldrep JC; Densmore CL
    Mol Biotechnol; 2003 Jan; 23(1):51-60. PubMed ID: 12611269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to inhaled gene therapy of obstructive lung diseases: A review.
    Kim N; Duncan GA; Hanes J; Suk JS
    J Control Release; 2016 Oct; 240():465-488. PubMed ID: 27196742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized Medications for Gene and Peptide Therapy.
    Laube BL
    Respir Care; 2015 Jun; 60(6):806-21; discussion 821-4. PubMed ID: 26070576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled gene delivery: a formulation and delivery approach.
    Gomes Dos Reis L; Svolos M; Hartwig B; Windhab N; Young PM; Traini D
    Expert Opin Drug Deliv; 2017 Mar; 14(3):319-330. PubMed ID: 27426972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primate.
    McDonald RJ; Lukason MJ; Raabe OG; Canfield DR; Burr EA; Kaplan JM; Wadsworth SC; St George JA
    Hum Gene Ther; 1997 Mar; 8(4):411-22. PubMed ID: 9054516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Gene therapy for lung cancer.
    Swisher SG; Roth JA
    Curr Oncol Rep; 2002 Jul; 4(4):334-40. PubMed ID: 12044243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, preparation and application of nucleic acid delivery carriers.
    Yang J; Liu H; Zhang X
    Biotechnol Adv; 2014; 32(4):804-17. PubMed ID: 24239630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy.
    Densmore CL
    Curr Cancer Drug Targets; 2003 Aug; 3(4):275-86. PubMed ID: 12871058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle Technology: Having Impact, but Needing Further Optimization.
    Moghimi SM; Wagner E
    Mol Ther; 2017 Jul; 25(7):1461-1463. PubMed ID: 28625572
    [No Abstract]   [Full Text] [Related]  

  • 16. Lentivirus-mediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice.
    Hwang SK; Kwon JT; Park SJ; Chang SH; Lee ES; Chung YS; Beck GR; Lee KH; Piao L; Park J; Cho MH
    Gene Ther; 2007 Dec; 14(24):1721-30. PubMed ID: 17960162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology.
    Chaudhary S; Singh A; Kumar P; Kaushik M
    J Biochem Mol Toxicol; 2021 Jul; 35(7):e22784. PubMed ID: 33826765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy.
    Garcia-Contreras L; Hickey AJ
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1491-504. PubMed ID: 12458157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.
    Mansouri S; Lavigne P; Corsi K; Benderdour M; Beaumont E; Fernandes JC
    Eur J Pharm Biopharm; 2004 Jan; 57(1):1-8. PubMed ID: 14729076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for pulmonary diseases.
    Kolb M; Martin G; Medina M; Ask K; Gauldie J
    Chest; 2006 Sep; 130(3):879-84. PubMed ID: 16963689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.